Robert Kramer's Net Worth
$20.9 Million
Who is Robert Kramer?
Robert Kramer has an estimated net worth of $20.9 Million. This is based on reported shares across multiple companies, which include Emergent BioSolutions Inc., and Aptevo Therapeutics Inc..
SEC CIK
Robert Kramer's CIK is 0001380956
Past Insider Trading and Trends
2016 was Robert Kramer's most active year for acquiring shares with 40 total transactions. Robert Kramer's most active month to acquire stocks was the month of March. 2007 was Robert Kramer's most active year for disposing of shares, totalling 48 transactions. Robert Kramer's most active month to dispose stocks was the month of May. 2022 saw Robert Kramer paying a total of $5,599,955.40 for 229,009 shares, this is the most they've acquired in one year. In 2021 Robert Kramer cashed out on 186,498 shares for a total of $19,237,993.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Emergent BioSolutions Inc. (EBS) Snapshot price: $7.55
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +72.27% | 212.31K |
—
|
—
| 506.06K |
Jun 9
| |||
Form 4
| +24.44% | 57.69K |
—
|
—
| 293.75K |
Mar 2
| |||
Form 4
| -3.03% | -3.23K |
$12.38 | -$39,937.88 | 103.3K |
Feb 28
| |||
Form 4
| -2.76% | -3.02K |
$13.99 | -$42,233.01 | 106.52K |
Feb 23 - Feb 24
| |||
Form 4
| -4.09% | -4.67K |
$13.25 | -$65,508.00 | 109.54K |
Feb 8
| |||
Form 4
| +55.06% | 87.7K |
$39.64 | -$67,982.60 | 246.97K |
Feb 28 - Mar 1
| |||
Form 4
| -2.12% | -3.45K |
$42.37 | -$146,308.35 | 159.27K |
Feb 23 - Feb 24
| |||
Form 4
| -0.20% | -331.00 |
$42.23 | -$194,046.85 | 162.72K |
Feb 22
| |||
Form 4
| -0.06% | -94.00 |
$61.62 | -$5,792.28 | 163.05K |
May 8
| |||
Form 4
| +18.05% | 24.95K |
$95.38 | -$476,971.65 | 163.15K |
Feb 24 - Feb 26
| |||
Form 4
| -0.73% | -1.01K |
$123.45 | -$529,970.85 | 138.2K |
Feb 9
| |||
Form 4
|
—
|
0
|
$75.41 | -$4,051,040.49 | 139.21K |
Scheduled
|
Feb 8
| ||
Form 4
|
—
|
0
|
$68.24 | -$2,016,885.60 | 139.21K |
Scheduled
|
Jan 20 - Jan 21
| ||
Form 4
|
—
|
0
|
$65.82 | -$1,529,454.48 | 139.21K |
Scheduled
|
Jan 15
| ||
Form 4
| -0.07% | -95.00 |
$79.25 | -$7,528.75 | 142.2K |
May 8
| |||
Form 4
| +27.74% | 30.9K |
$59.44 | -$146,339.20 | 142.3K |
Feb 25 - Feb 27
| |||
Form 4
| -0.09% | -95.00 |
$47.49 | -$4,511.55 | 111.39K |
May 8
| |||
Form 4
| +22.28% | 20.32K |
$58.93 | -$193,593.18 | 111.49K |
Feb 26 - Feb 28
| |||
Form 4
| +1.44% | 1.29K |
—
|
—
| 91.17K |
May 8
| |||
Form 4
| -1.89% | -1.73K |
$51.84 | -$89,527.68 | 89.88K |
Mar 9
| |||
Form 4
| +11.59% | 9.51K |
$49.86 | -$115,823.57 | 91.61K |
Feb 27 - Feb 28
| |||
Form 4
| -5.65% | -4.92K |
$31.02 | -$152,477.19 | 82.09K |
Mar 9 - Mar 10
| |||
Form 4
| +27.34% | 18.68K |
$30.63 | -$55,103.37 | 87.01K |
Aug 1 - Feb 28
| |||
Form 4/A
| -6.55% | -5.25K |
$29.15 | -$678,586.95 | 74.83K |
Scheduled
|
Apr 1
| ||
Form 4
| -3.65% | -2.62K |
$30.82 | -$411,985.92 | 69.16K |
Scheduled
|
Apr 6
| ||
Form 4
| -4.07% | -3.04K |
$29.79 | -$382,885.15 | 71.79K |
Scheduled
|
Mar 11 - Apr 4
| ||
Form 4
| -6.55% | -5.25K |
$29.15 | -$678,586.95 | 74.83K |
Apr 1
| |||
Form 4
| -5.41% | -4.58K |
$34.47 | -$157,924.28 | 80.08K |
Mar 9 - Mar 10
| |||
Form 4
| +21.15% | 14.78K |
—
|
—
| 84.66K |
Mar 1
| |||
Form 4
| -1.74% | -1.23K |
$33.53 | -$41,376.02 | 69.88K |
Nov 4
| |||
Form 4
| +22.95% | 13.27K |
$29.00 | -$93,955.78 | 71.11K |
Mar 10 - Mar 11
| |||
Form 4
| -6.26% | -3.86K |
$23.46 | -$90,619.78 | 57.84K |
Scheduled
|
Nov 4 - Nov 7
| ||
Form 4
| -44.66% | -50.19K |
$24.34 | -$1,221,704.04 | 62.18K |
Scheduled
|
Apr 15 - Apr 16
| ||
Form 4
| +30.15% | 26.03K |
—
|
—
| 112.37K |
Mar 11
| |||
Form 4
| -1.39% | -1.22K |
$19.58 | -$23,868.02 | 86.34K |
Nov 4
| |||
Form 4
| +198.73% | 58.25K |
—
|
—
| 87.56K |
May 31
| |||
Form 4
| +15.53% | 3.94K |
—
|
—
| 29.31K |
Mar 12
| |||
Form 4
| +83.32% | 11.53K |
—
|
—
| 25.37K |
Nov 5
| |||
Form 4
| -2.05% | -290.00 |
$14.79 | -$4,289.10 | 13.84K |
Oct 3
| |||
Form 4
| -66.46% | -28.00K |
$14.82 | -$414,960.00 | 14.13K |
Sep 6
| |||
Form 4
| -12.23% | -5.87K |
$14.79 | -$86,817.30 | 42.13K |
Aug 13
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +8.71% | 12.98K |
$4.95 | -$239,088.00 | 162.11K |
Scheduled
|
Jun 28 - Jun 29
| ||
Form 4
| +8.97% | 12.28K |
$4.78 | -$237,320.01 | 149.13K |
Scheduled
|
Jun 26 - Jun 27
| ||
Form 4
| +12.47% | 15.18K |
$4.57 | -$200,415.79 | 136.85K |
Scheduled
|
Jun 22 - Jun 25
| ||
Form 4
| +16.63% | 17.35K |
$4.64 | -$183,591.92 | 121.67K |
Scheduled
|
Jun 20 - Jun 21
| ||
Form 4
| +17.38% | 15.45K |
$5.02 | -$218,054.02 | 104.32K |
Scheduled
|
Jun 18 - Jun 19
| ||
Form 4
| +20.56% | 15.16K |
$4.53 | -$198,714.09 | 88.88K |
Scheduled
|
Jun 14 - Jun 15
| ||
Form 4
| +88.83% | 34.68K |
$4.33 | -$293,652.50 | 73.72K |
Scheduled
|
Jun 12 - Jun 13
| ||
Form 4
| +117.91% | 21.12K |
$4.35 | -$168,598.84 | 39.04K |
Scheduled
|
Jun 8 - Jun 11
| ||
Form 4
|
∞
| 17.92K |
$4.51 | -$246,968.36 | 17.92K |
Scheduled
|
Jun 6 - Jun 7
| ||
Form 4
|
—
|
0
|
$4.85 | -$266,831.58 |
0
|
Scheduled
|
Jun 4 - Jun 5
| ||
Form 4
|
—
|
0
|
$5.10 | -$280,439.71 |
0
|
Scheduled
|
May 31 - Jun 1
| ||
Form 4
|
—
|
0
|
$5.27 | -$293,449.20 |
0
|
Scheduled
|
May 29 - May 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aptevo Therapeutics Inc. (APVO) Snapshot price: $0.325
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||